[Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
作者信息
Calvet J M, Matarrodona M, Bordas R
出版信息
Rev Iber Endocrinol. 1974 Jul-Aug;21(124):347-62.
PMID:4453782
Abstract
摘要
相似文献
1
[Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
Rev Iber Endocrinol. 1974 Jul-Aug;21(124):347-62.
2
[Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
Rev Iber Endocrinol. 1974 Sep-Oct;21(125):427-30, 433-8, 441-2 passim.
3
[Clinical trial with glypentide. Comparison with the hypoglycemic activity of other sulfonylurea compounds].
Rev Iber Endocrinol. 1976 Mar-Apr;23(134):181-96.
4
[A new antidiabetic agent: glyclazide. A study of glycemic regulation].[一种新型抗糖尿病药物：格列齐特。血糖调节研究]
Nouv Presse Med. 1974 Feb 2;3(5):249-51.
5
[Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
Rev Iber Endocrinol. 1973 May-Jun;20(117):289-303.
6
[Clinical trial of glypizide].
Rev Iber Endocrinol. 1974 Jan;21(121):61-73.
7
[Long term study of a new antidiabetic agent in 1183 cases].[1183例患者使用新型抗糖尿病药物的长期研究]
Sem Hop Ther. 1974 Feb;50(2):133-9.
8
[Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].[一种具有血管作用的新型抗糖尿病药物的治疗试验：1702 SE]
Lille Med. 1972 Oct;17(9):Suppl 6:1332-6.
9
Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
Isr J Med Sci. 1972 Jun;8(6):888-92.
10
A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).新型口服降糖药格列吡嗪（K 4024）的对照临床试验。
Arzneimittelforschung. 1972 Jul;22(7):1169-73.
Zotero 插件